Medicines for Europe welcomes decision on EMA relocation to Amsterdam

21 November 2017

Medicines for Europe is very glad to see the Council […]

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017

Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs

18 October 2017

On Thursday 12 October, the Directorate-general for Internal Market, Industry, […]

Medicines for Europe announces new President, launches Access to Medicines campaign

10 October 2017

The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]

Medicines for Europe to join the ISPOR Issue Panel on value added medicines

5 October 2017

Value added medicines represent a major opportunity to improve patients’ […]

Medicines for Europe llama a poner en marcha políticas para evitar desabastecimientos

29 September 2017

Addressing medicine shortages in Europe: Competition is crucial for patient access

29 September 2017

Generic medicines have proven to be pivotal in increasing patient […]

Europe needs change to drive added value

15 September 2017

European report calms common concerns

15 September 2017

2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments

12 September 2017

Biosimilar medicines are transforming treatment by enabling better access to […]